Click image to enlargeAre you experiencing pain from fibromyalgia?
The purpose of this study is to determine how effective the investigational study drug is at reducing the pain and associated symptoms in patients who have fibromyalgia.
About 240 people in the United States will participate in this study. Participants have a one in three chance of receiving the placebo (inactive substance). Study participation will last about 35 weeks and there will be 8 visits to our center.